Ciprofloxacin: Spontaneous Bacterial Peritonitis (Prevention)
Joyce A Generali1, Dennis J Cada2
1Editor-in-Chief, Hospital Pharmacy , and Clinical Professor, Emeritus, Department of Pharmacy Practice, University of Kansas, School of Pharmacy , Kansas City/Lawrence, Kansas ,
Hospital Pharmacy
|December 31, 2015
Summary
This guide helps healthcare professionals quickly find and evaluate literature on unapproved drug uses (off-label drug uses). It supports rational patient care decisions by providing access to published studies and comprehensive references.
Area of Science:
- Pharmacy
- Pharmacology
- Clinical Practice
Background:
- Off-label drug use refers to prescribing medications for conditions not approved by the US Food and Drug Administration (FDA).
- Practitioners require reliable resources to navigate the complexities of unapproved drug indications.
Purpose of the Study:
- To introduce a practitioner-oriented resource, Off-Label Drug Facts, for information on specific unapproved drug uses.
- To enable healthcare professionals to efficiently identify and assess the rationality of off-label drug applications in patient care.
Main Methods:
- Extraction of content from the Off-Label Drug Facts publication.
- Compilation of literature references to support off-label drug use evaluations.
Main Results:
- Provides a guide to published literature on off-label drug uses.
- Facilitates rapid identification of studies relevant to specific patient care scenarios.
Conclusions:
- Off-Label Drug Facts serves as a valuable tool for clinicians seeking evidence-based information on unapproved drug indications.
- The resource supports informed decision-making in patient care by directing users to comprehensive literature.
Related Concept Videos
01:28Inhibitors of Bacterial DNA Synthesis
28
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These...
28
01:17Transmission-based Precautions I: Contact, Enteric, and Droplets
5.0K
Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
5.0K
01:22Healthcare Associated Infections II: Preventive Measures
4.9K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.9K
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
634
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
634
01:17Urinary Tract Infection IV: Nursing Management
594
In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs...
594
01:27Acute Pyelonephritis I: Introduction
1.1K
Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
1.1K